Chongqing Zhifei Bio Products - Asset Resilience Ratio

Latest as of September 2023: -0.08%

Chongqing Zhifei Bio Products (300122) has an Asset Resilience Ratio of -0.08% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of Chongqing Zhifei Bio Products to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥-41.38 Million

≈ $-6.05 Million USD Cash + Short-term Investments

Total Assets

CN¥49.27 Billion

≈ $7.21 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how Chongqing Zhifei Bio Products's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Chongqing Zhifei Bio Products.

Liquid Assets Composition Over Time

This chart breaks down Chongqing Zhifei Bio Products's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 300122 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥-41.38 Million	-0.08%
Total Liquid Assets	CN¥-41.38 Million	-0.08%

Asset Resilience Insights

Limited Liquidity: Chongqing Zhifei Bio Products maintains only -0.08% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Chongqing Zhifei Bio Products Industry Peers by Asset Resilience Ratio

Compare Chongqing Zhifei Bio Products's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Aurinia Pharmaceuticals Inc NASDAQ:AUPH	Biotechnology	33.23%
Nanobiotix NASDAQ:NBTX	Biotechnology	4.71%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	65.12%

Annual Asset Resilience Ratio for Chongqing Zhifei Bio Products (2014–2024)

The table below shows the annual Asset Resilience Ratio data for Chongqing Zhifei Bio Products.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.02%	CN¥11.53 Million ≈ $1.69 Million	CN¥49.91 Billion ≈ $7.30 Billion	+0.05pp
2022-12-31	-0.03%	CN¥-10.15 Million ≈ $-1.49 Million	CN¥38.00 Billion ≈ $5.56 Billion	+0.14pp
2021-12-31	-0.17%	CN¥-51.45 Million ≈ $-7.53 Million	CN¥30.05 Billion ≈ $4.40 Billion	+0.15pp
2020-12-31	-0.32%	CN¥-49.19 Million ≈ $-7.20 Million	CN¥15.22 Billion ≈ $2.23 Billion	-0.76pp
2019-12-31	0.44%	CN¥48.09 Million ≈ $7.04 Million	CN¥10.94 Billion ≈ $1.60 Billion	+0.92pp
2018-12-31	-0.49%	CN¥-33.04 Million ≈ $-4.84 Million	CN¥6.81 Billion ≈ $996.54 Million	-0.38pp
2017-12-31	-0.11%	CN¥-4.41 Million ≈ $-644.69K	CN¥4.11 Billion ≈ $600.82 Million	+0.14pp
2016-12-31	-0.25%	CN¥-6.76 Million ≈ $-989.50K	CN¥2.71 Billion ≈ $396.48 Million	-0.28pp
2015-12-31	0.03%	CN¥782.09K ≈ $114.44K	CN¥2.68 Billion ≈ $392.41 Million	+0.39pp
2014-12-31	-0.36%	CN¥-9.72 Million ≈ $-1.42 Million	CN¥2.71 Billion ≈ $397.21 Million	--

pp = percentage points

About Chongqing Zhifei Bio Products

SHE:300122 China Biotechnology

Market Cap

$4.28 Billion

CN¥29.23 Billion CNY

Market Cap Rank

#3942 Global

#569 in China

Share Price

CN¥12.21

Change (1 day)

-2.40%

52-Week Range

CN¥11.37 - CN¥22.66

All Time High

CN¥11976.62